Catherine E. Hanratty

Catherine E. Hanratty

Auto-generated profile, based on publicly available information

Catherine E. Hanratty

Discipline in Physiotherapy School of Life and Health Sciences University of Ulster Newtownabbey United Kingdom

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PMP. Jane McDowell
P. Jane McDowell
JBJohn Busby
John Busby
CHCatherine E. Hanratty
Catherine E. Hanratty
RDRatko Djukanovic
Ratko Djukanovic
AWAshley Woodcock
Ashley Woodcock
LHLiam G. Heaney
Liam G. Heaney
Rationale: The past 25 years have seen huge progress in understanding of the pathobiology of type-2 (T2) asthma, identification of measurable biomarkers, and the emergence of novel monoclonal antibody treatments. Although present in a minority of patients with severe asthma, very little is known about the mechanisms underlying T2-low asthma, making it a significant unmet need in asthma research. Objectives: The objective of this study was to explore the differences between study exacerbators and nonexacerbators, to describe physiological changes at exacerbation in those who are T2HIGH and T2LOW at the time of exacerbation, and to evaluate the stability of inflammatory phenotypes when stable and at exacerbation. Methods: Exacerbation assessment was a prespecified secondary analysis of data from a 48-week, multicenter, randomized controlled clinical study comparing the use of biomarkers and symptoms to adjust steroid treatment in a T2-low severe asthma–enriched cohort. Participants were phenotyped as T2LOW (fractional exhaled nitric oxide ⩽ 20 ppb and blood eosinophil count ⩽ 150 cells/µl) or T2HIGH (fractional exhaled nitric oxide > 20 or blood eosinophil count > 150) at study enrollment and at each exacerbation. Here, we report the findings of the exacerbation analyses, including comparison of exacerbators and nonexacerbators, the physiological changes at exacerbation in those who had evidence of T2 biology at exacerbation versus those that did not, and the stability of inflammatory phenotypes when stable and at exacerbation. Measurements and Main Results: Of the 301 participants, 60.8% (183) had one or more self-reported exacerbations (total of 390). Exacerbators were more likely to be female, have a higher body mass index, and have more exacerbations requiring oral corticosteroid and unscheduled primary care attendances for exacerbations. At enrollment, 23.6% (71) were T2LOW and 76.4% (230) T2HIGH. The T2LOW group had more asthma primary care attendances, were more likely to have a previous admission to HDU (high dependency unit)/ICU and to be receiving maintenance oral corticosteroids. At exacerbation, the T2LOW events were indistinguishable from T2HIGH exacerbations in terms of lung function (mean fall in T2LOW FEV1, 200 [400] ml vs. T2HIGH 200 [300] ml; P = 0.93) and symptom increase (ACQ5: T2LOW, 1.4 [0.8] vs. T2HIGH, 1.3 [0.8]; P = 0.72), with no increase in T2 biomarkers from stable to exacerbation state in the T2LOW exacerbations. The inflammatory phenotype within individual patients was dynamic; inflammatory phenotype at study entry did not have a significant association with exacerbation phenotype. Conclusions: Asthma exacerbations demonstrating a T2LOW phenotype were physiologically and symptomatically similar to T2HIGH exacerbations. T2LOW asthma was an unstable phenotype, suggesting that exacerbation phenotyping should occur at the time of exacerbation. The clinically significant exacerbations in participants without evidence of T2 biology at the time of exacerbation highlight the unmet and pressing need to further understand the mechanisms at play in non-T2 asthma. Clinical trial registered with www.clinicaltrials.gov (NCT02717689).

11 March 2022 in JMIR Rehabilitation and Assistive Technologies
Verified
Journal Article
Open access
JAJonathon M R Agnew
Jonathon M R Agnew
CHCatherine E Hanratty
Catherine E Hanratty
JMJoseph McVeigh
Joseph McVeigh
Chris NugentChris Nugent
Chris Nugent
DKDaniel Kerr
Daniel Kerr
Background: Musculoskeletal physiotherapy provides conservative management for a range of conditions. Currently, there is a lack of engagement with exercise programs because of the lack of supervision and low self-efficacy. The use of mobile health (mHealth) interventions could be a possible solution to this problem, helping promote self-management at home. However, there is little evidence for musculoskeletal physiotherapy on the most effective forms of mHealth. Objective: The aim of this review is to investigate the literature focusing on the use of mHealth in musculoskeletal physiotherapy and summarize the evidence. Methods: A scoping review of 6 peer-reviewed databases was conducted in March 2021. No date limits were applied, and only articles written in the English language were selected. A reviewer screened all the articles, followed by 2 additional researchers screening a random sample before data extraction. Results: Of the 1393 studies, 28 (2.01%) were identified. Intervention characteristics comprised stretching and strengthening exercises, primarily for degenerative joint pain and spinal conditions (5/28, 18%). The most reported use of mHealth included telephone and videoconferencing calls to provide a home exercise program or being used as an adjunct to physiotherapy musculoskeletal assessment (14/28, 50%). Although patient satisfaction with mHealth was reported to be high, reasons for disengagement included a lack of high-quality information and poor internet speeds. Barriers to clinical uptake included insufficient training with the intervention and a lack of time to become familiar. Conclusions: mHealth has some benefits regarding treatment adherence and can potentially be as effective as normal physiotherapy care while being more cost-effective. The current use of mHealth is most effective when ongoing feedback from a health care professional is available.

26 May 2022 in JMIR Formative Research
Verified
Journal Article
Open access
JAJonathon M R Agnew
Jonathon M R Agnew
Chris NugentChris Nugent
Chris Nugent
CHCatherine E Hanratty
Catherine E Hanratty
EMElizabeth Martin
Elizabeth Martin
DKDaniel Kerr
Daniel Kerr
JMJoseph McVeigh
Joseph McVeigh
Background: The successful rehabilitation of musculoskeletal pain requires more than medical input alone. Conservative treatment, including physiotherapy and exercise therapy, can be an effective way of decreasing pain associated with musculoskeletal pain. However, face-to-face appointments are currently not feasible. New mobile technologies, such as mobile health technologies in the form of an app for smartphones, can be a solution to this problem. In many cases, these apps are not backed by scientific literature. Therefore, it is important that they are reviewed and quality assessed. Objective: The aim is to evaluate and measure the quality of apps related to shoulder pain by using the Mobile App Rating Scale. Methods: This study included 25 free and paid apps—8 from the Apple Store and 17 from the Google Play Store. A total of 5 reviewers were involved in the evaluation process. A descriptive analysis of the Mobile App Rating Scale results provided a general overview of the quality of the apps. Results: Overall, app quality was generally low, with an average star rating of 1.97 out of 5. The best scores were in the “Functionality” and “Aesthetics” sections, and apps were scored poorer in the “Engagement” and “Information” sections. The apps were also rated poorly in the “Subjective Quality” section. Conclusions: In general, the apps were well built technically and were aesthetically pleasing. However, the apps failed to provide quality information to users, which resulted in a lack of engagement. Most of the apps were not backed by scientific literature (24/25, 96%), and those that contained scientific references were vastly out-of-date. Future apps would need to address these concerns while taking simple measures to ensure quality control.

18 October 2021 in JMIR Preprints
Verified
Preprint
Open access
JAJonathon M R Agnew
Jonathon M R Agnew
Chris NugentChris Nugent
Chris Nugent
CHCatherine E Hanratty
Catherine E Hanratty
EMElizabeth Martin
Elizabeth Martin
DKDaniel Kerr
Daniel Kerr
JMJoseph McVeigh
Joseph McVeigh
BACKGROUND The successful rehabilitation of musculoskeletal pain requires more than medical input alone. Conservative treatment, including physiotherapy and exercise therapy, can be an effective way of decreasing pain associated with musculoskeletal pain. However, face-to-face appointments are currently not feasible. New mobile technologies, such as mobile health technologies in the form of an app for smartphones, can be a solution to this problem. In many cases, these apps are not backed by scientific literature. Therefore, it is important that they are reviewed and quality assessed. OBJECTIVE The aim is to evaluate and measure the quality of apps related to shoulder pain by using the Mobile App Rating Scale. METHODS This study included 25 free and paid apps—8 from the Apple Store and 17 from the Google Play Store. A total of 5 reviewers were involved in the evaluation process. A descriptive analysis of the Mobile App Rating Scale results provided a general overview of the quality of the apps. RESULTS Overall, app quality was generally low, with an average star rating of 1.97 out of 5. The best scores were in the “Functionality” and “Aesthetics” sections, and apps were scored poorer in the “Engagement” and “Information” sections. The apps were also rated poorly in the “Subjective Quality” section. CONCLUSIONS In general, the apps were well built technically and were aesthetically pleasing. However, the apps failed to provide quality information to users, which resulted in a lack of engagement. Most of the apps were not backed by scientific literature (24/25, 96%), and those that contained scientific references were vastly out-of-date. Future apps would need to address these concerns while taking simple measures to ensure quality control.

1 June 2012 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
CHC.E. Hanratty
C.E. Hanratty
JMJoseph McVeigh
Joseph McVeigh
DKD.P. Kerr
D.P. Kerr
JBJ.R. Basford
J.R. Basford
MFM.B. Finch
M.B. Finch
JSJulius Sim
Julius Sim
Background Exercise is a fundamental part of the management of subacromial impingement syndrome (SAIS), yet there has been relatively little examination of exercise interventions for this condition. Previous reviews in this area contain few randomized controlled trials (RCTs), have significant weaknesses, and none have conducted a rigorous meta-analysis of the data specifically related to exercise intervention. Questions remain regarding the overall effectiveness of exercise intervention in SAIS for example; which muscles should be targeted; and what is the optimal strengthening approach. The inconsistency of treatment and lack of guidelines may be reflected in the poor long-term outcome of conservative management of SAIS.1,2 Objectives To evaluate the effectiveness of exercise in the treatment of people with SAIS. Methods A systematic review and meta-analysis was conducted. Ten electronic databases were searched from the dates of their inception until August 2010. Included studies were RCTs investigating exercise in the management of SAIS. Outcomes were pain, strength, function, and quality of life. Data were summarised qualitatively using a best evidence synthesis. Treatment effect size and variance of individual studies were used to give an overall summary effect and data were converted to standardised mean difference with 95% confidence intervals (SMD (CI)). Results Sixteen studies were included (total number of study participants=1162). There was strong evidence that exercise decreases pain and improves function at short term follow-up. There was also moderate evidence that exercise results in short term improvement in mental well-being and a long-term improvement in function, for those with SAIS. There was limited evidence that exercise reduced pain at long term follow-up. It was not possible to comment on the effect of exercise on long-term quality of life due to insufficient evidence. The most common risk of bias across the studies was inadequately concealed treatment allocation. Six studies in the review were suitable for meta-analysis. Exercise had a small positive effect on strength of the rotator cuff in the short term (SMD -0.46 (-0.76, 0.16); p=0.003), and a small positive effect on long-term function (SMD -0.31 (-0.57, 0.04); p=0.020). There was no statistically significant effect of exercise on short-term function. Conclusions Physiotherapy exercises are effective in the management of SAIS. However, heterogeneity of the exercise interventions, coupled with poor reporting of exercise protocols, prevented conclusions being drawn about which specific components of the exercise protocols (i.e. type, intensity, frequency and duration) were associated with best outcomes. Desmeules F, Côté CH, Frémont P. Therapeutic exercise and orthopaedic manual therapy for impingement syndrome: a systematic review. Clin J Sports Med. 2003;13:176–182. Reilingh ML, Kuijpers T, Tanja-Hafterkamp AM, van der Windt DA. Course and prognosis of shoulder symptoms in general practice. Rheumatology. 2008;47:724–730. Disclosure of Interest None Declared

15 September 2021 in JMIR Preprints
Verified
Preprint
Open access
JAJonathon M R Agnew
Jonathon M R Agnew
CHCatherine E Hanratty
Catherine E Hanratty
JMJoseph McVeigh
Joseph McVeigh
Chris NugentChris Nugent
Chris Nugent
DKDaniel Kerr
Daniel Kerr
BACKGROUND Musculoskeletal physiotherapy provides conservative management for a range of conditions. Currently, there is a lack of engagement with exercise programs because of the lack of supervision and low self-efficacy. The use of mobile health (mHealth) interventions could be a possible solution to this problem, helping promote self-management at home. However, there is little evidence for musculoskeletal physiotherapy on the most effective forms of mHealth. OBJECTIVE The aim of this review is to investigate the literature focusing on the use of mHealth in musculoskeletal physiotherapy and summarize the evidence. METHODS A scoping review of 6 peer-reviewed databases was conducted in March 2021. No date limits were applied, and only articles written in the English language were selected. A reviewer screened all the articles, followed by 2 additional researchers screening a random sample before data extraction. RESULTS Of the 1393 studies, 28 (2.01%) were identified. Intervention characteristics comprised stretching and strengthening exercises, primarily for degenerative joint pain and spinal conditions (5/28, 18%). The most reported use of mHealth included telephone and videoconferencing calls to provide a home exercise program or being used as an adjunct to physiotherapy musculoskeletal assessment (14/28, 50%). Although patient satisfaction with mHealth was reported to be high, reasons for disengagement included a lack of high-quality information and poor internet speeds. Barriers to clinical uptake included insufficient training with the intervention and a lack of time to become familiar. CONCLUSIONS mHealth has some benefits regarding treatment adherence and can potentially be as effective as normal physiotherapy care while being more cost-effective. The current use of mHealth is most effective when ongoing feedback from a health care professional is available.